Search Results 881-890 of 21124 for Informed consent

1. Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer - Mayo Clinic

   Provide written informed consent; Willing to return to enrolling institution for follow-up (during the active monitoring phase of the study); Willing to ...

2. A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases - Mayo Clinic

   Male or female subjects of minimum adult legal age (according to local laws for signing the informed consent document), able to provide written informed consent ...

3. A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Effectiveness of Isatuximab in Patients Awaiting Kidney Transplantation - Mayo Clinic

   Capable of giving signed informed consent. For Participants in Cohort A. Active candidates on the kidney waitlist with living donor. For Participants in ...

4. Metabolic Agents Pharmacodynamic Analyses After Brain Radiation - Mayo Clinic

   Provide written informed consent for the current study. Willing to undergo at least one MRI (at most two) with proton and/or phosphorus magnetic resonance ...

5. Study of RP-6306 With Gemcitabine in Advanced Solid Tumors - Mayo Clinic

   Male or female and ≥ 18 years-of-age at the time of informed consent. ECOG Performance status 0 or 1. Locally advanced or metastatic resistant or ...

6. Study Of [18F]FAPI-74 PET In Patients With Gastrointestinal Cancers (18F-FAPI-74 GI) - Mayo Clinic

   Anatomic imaging (e.g., CT, MRI) obtained within ≤ 28 days of consent. Age ≥ 18 years. Completed informed consent as determined per the IRB of record.

7. A Study To Evaluate The Effectiveness Of VERIS CMV Assay To Measure Cytomegalovirus (CMV) As An Aid For Monitoring The Response Of The Virus To Therapy - Mayo Clinic

   Written Informed Consent obtained; Male or Female; Any race or ethnicity; ≥ 18 years old; Must have had a kidney transplant and has been evaluated for post ...

8. The TOGETHER Project - Transplant Organ Genomics to Help Prevent Rejection in Heart Transplant Recipients - Mayo Clinic

   Participation eligibility · Adult (≥18 years) solitary heart transplant recipient · Patient is willing and able to provide informed written consent.

9. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

   Subjects must have signed and dated an IRB/IEC approved written informed consent form in accordance with regulatory and institutional guidelines. This must ...

10. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery (DISCOVERY) - Mayo Clinic

    Able to provide informed consent by self or via proxy. Fluent in English or Spanish prior to stroke onset. Exclusion Criteria: Documented history of pre ...